Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > Hyoscyamine Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Hyoscyamine Treatment Report

Brand Names: Levsin

What is Hyoscyamine? Hyoscyamine is an anticholinergic drug used in the treatment of gastrointestinal disorders including cramp, irritable bowel syndrome, and peptic ulcers; for rigidity, tremors, excess saliva in parkinsonism; as a drying agent in acute rhinitis. Read more...Click to read more below

See more information, including instructions, precautions, side effects, and interactions.


Reasons taken

18 patients in the community are taking or have taken Hyoscyamine.

Reason # Patients Percentage of patients
Excess saliva 11 61%
Other 5 27%
disease-related symptoms 1 5%

Dosages

Based on the patients currently taking Hyoscyamine.

Top 10 (Show all)

All (Show top 10)

  0.125ml as needed 0.5 mg/mL as needed 10ml as needed 2tps. as needed 0.25 ml daily 4 x 0.125 mg/5 mL daily 0.75 mg daily 1 mL daily 8 mL daily 20 mL daily 125 mL daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Hyoscyamine or how long patients were taking Hyoscyamine before stopping.

Currently Taking Hyoscyamine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
1
3
3

Stopped Taking Hyoscyamine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
2
0
0
0
Why Patients Stopped Taking Hyoscyamine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 2 100% Other: 100%
Did not seem to work 1 50% Did not seem to work: 50%
Side effects too severe 1 50% Side effects too severe: 50%

Report created on November 08, 2009.